We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Congressional probe found 22 consultants had advised both the US FDA and drug manufacturers over a decade
Members of Sackler family who owned OxyContin maker will increase financial contribution but still receive a legal shield
Proposal revealed by court mediator comes after a judge rejected earlier deal
The pharmaceuticals company has returned to financial health and is exploring a dual UK-US listing
With more than 270 people dying every day, authorities are under pressure to treat, rather than prosecute, users
Sackler family was to make multibillion-dollar contribution in exchange for protection from lawsuits
Move is the latest fallout for members of the family that owned opioid maker Purdue Pharma
Ohio ruling is first time CVS, Walgreens and Walmart have been held culpable at conclusion of a trial
Concerns raised over Robert Califf’s previous stint at the US drugs regulator and its approach to the opioid epidemic
Writer Beth Macy and director Barry Levinson discuss taking on the Sacklers and victim-blaming in their mini-series
Judge approves bankruptcy plan for opioid maker in which family will pay $4.5bn
Critics say concessions in case regarding the company diminishes accountability in overdose scandal
US attorneys-general announce agreement with Johnson & Johnson and drug distribution giants
Agreement would resolve thousands of lawsuits over deadly painkiller epidemic
Agreement with holdouts brings US drugmaker a step closer to emerging from bankruptcy
Platforms gain entry to sensitive user information such as phone number and IP address
Revenues will be up to 18% higher than originally expected
Pharma group avoids going to trial with other drugmakers and distributors next week
UK drugmaker stands by payout based on ‘absence of any findings of personal wrongdoing’ in US opioid case
Patrick Radden Keefe’s saga of how a pharmaceutical dynasty unleashed a wave of dependency and grew rich from it
Gangs use long-established networks to export synthetic narcotics to the US
Johnson & Johnson, Teva, Endo and Allergan face latest test in legal fallout from epidemic
Agreement brings consultancy’s total bill for prescription painkiller advice to $619m
Owners of opioid maker Purdue Pharma pledge extra money to win over US states that rejected deal
Answers emerge as to the unexplained departures from the consultancy’s investment banking research unit
International Edition
